Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
FTRE Transcript
Fortrea Holdings Inc. (FTRE) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call summary and Q&A indicate a positive outlook. Financial performance shows improvement, with debt repayment and DSO enhancements. Product development is strong, with AI deployment plans and a healthy biotech market. Market strategy is optimistic, with increased RFP flow and stable bookings. Financial health is stable, with cost optimization and debt reduction. Shareholder returns are not explicitly mentioned but implied to be stable. The Q&A confirms positive sentiment, with cautious optimism in biotech and AI's role. Overall, the company's strong financial metrics, optimistic guidance, and operational improvements support a positive stock price prediction.
Fortrea Holdings Inc. (FTRE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
Fortrea Holdings Inc. (FTRE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Neutral12-2
Fortrea Holdings Inc. (FTRE) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call reveals several positive indicators: a 40% increase in RFP volume from new clients, improved decision-making timelines in biotech, and consistent pricing strategies. The company is focusing on optimizing contracts and achieving operating leverage, with no structural barriers to margin improvement. The CEO's positive surprise regarding workforce morale further supports a positive outlook. However, the lack of 2026 guidance and potential pricing pressures are cautionary notes. Given the market cap, the stock price is likely to react positively, within the 2% to 8% range.
FTRE Slides
Fortrea Q4 2025 slides: revenue dips, transformation advances amid headwinds2026-02-26
Fortrea Q3 2025 slides: Strategic initiatives drive stock surge despite earnings miss2025-11-05
Fortrea Q2 2025 slides: Revenue growth accelerates as new CEO takes helm2025-08-06
Fortrea Q1 2025 slides: $489M impairment charge overshadows EBITDA growth2025-05-12
FTRE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
